TrialBMC cancer2014

Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN study.

Amelie Deleporte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.